Literature DB >> 26945187

Indications, algorithms, and outcomes for coronary artery bypass surgery in patients with acute coronary syndromes.

Babatunde A Yerokun1, Judson B Williams, Jeffrey Gaca, Peter K Smith, Matthew T Roe.   

Abstract

For patients with a non-ST-segment elevation acute coronary syndrome (NSTE-ACS), guideline recommendations and treatment pathways focus on revascularization for definitive treatment if the patient is an appropriate candidate. Despite the widespread use of revascularization for NSTE-ACS, most patients undergo a percutaneous coronary intervention, whereas a minority of patients undergo coronary artery bypass grafting. Focusing specifically on the USA, the contemporary utilization, preoperative and perioperative considerations, and outcomes of NSTE-ACS patients undergoing coronary artery bypass grafting have not been comprehensively reviewed.

Entities:  

Mesh:

Year:  2016        PMID: 26945187      PMCID: PMC5142527          DOI: 10.1097/MCA.0000000000000364

Source DB:  PubMed          Journal:  Coron Artery Dis        ISSN: 0954-6928            Impact factor:   1.439


  48 in total

1.  2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Authors:  L David Hillis; Peter K Smith; Jeffrey L Anderson; John A Bittl; Charles R Bridges; John G Byrne; Joaquin E Cigarroa; Verdi J Disesa; Loren F Hiratzka; Adolph M Hutter; Michael E Jessen; Ellen C Keeley; Stephen J Lahey; Richard A Lange; Martin J London; Michael J Mack; Manesh R Patel; John D Puskas; Joseph F Sabik; Ola Selnes; David M Shahian; Jeffrey C Trost; Michael D Winniford
Journal:  Circulation       Date:  2011-11-07       Impact factor: 29.690

2.  Preoperative statin therapy is associated with reduced cardiac mortality after coronary artery bypass graft surgery.

Authors:  Charles D Collard; Simon C Body; Stanton K Shernan; Shirley Wang; Dennis T Mangano
Journal:  J Thorac Cardiovasc Surg       Date:  2006-08       Impact factor: 5.209

3.  Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial.

Authors:  Friedrich W Mohr; Marie-Claude Morice; A Pieter Kappetein; Ted E Feldman; Elisabeth Ståhle; Antonio Colombo; Michael J Mack; David R Holmes; Marie-angèle Morel; Nic Van Dyck; Vicki M Houle; Keith D Dawkins; Patrick W Serruys
Journal:  Lancet       Date:  2013-02-23       Impact factor: 79.321

4.  Aspirin plus clopidogrel versus aspirin alone after coronary artery bypass grafting: the clopidogrel after surgery for coronary artery disease (CASCADE) Trial.

Authors:  Alexander Kulik; Michel R Le May; Pierre Voisine; Jean-Claude Tardif; Robert Delarochelliere; Sarika Naidoo; George A Wells; Thierry G Mesana; Marc Ruel
Journal:  Circulation       Date:  2010-12-06       Impact factor: 29.690

5.  Population trends in the incidence and outcomes of acute myocardial infarction.

Authors:  Robert W Yeh; Stephen Sidney; Malini Chandra; Michael Sorel; Joseph V Selby; Alan S Go
Journal:  N Engl J Med       Date:  2010-06-10       Impact factor: 91.245

Review 6.  Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery.

Authors:  Kyle A Arsenault; Arif M Yusuf; Eugene Crystal; Jeff S Healey; Carlos A Morillo; Girish M Nair; Richard P Whitlock
Journal:  Cochrane Database Syst Rev       Date:  2013-01-31

7.  Trends in presenting characteristics and hospital mortality among patients with ST elevation and non-ST elevation myocardial infarction in the National Registry of Myocardial Infarction from 1990 to 2006.

Authors:  William J Rogers; Paul D Frederick; Edna Stoehr; John G Canto; Joseph P Ornato; C Michael Gibson; Charles V Pollack; Joel M Gore; Nisha Chandra-Strobos; Eric D Peterson; William J French
Journal:  Am Heart J       Date:  2008-11-01       Impact factor: 4.749

8.  Aspirin and mortality from coronary bypass surgery.

Authors:  Dennis T Mangano
Journal:  N Engl J Med       Date:  2002-10-24       Impact factor: 91.245

9.  Efficacy of Long-Term β-Blocker Therapy for Secondary Prevention of Long-Term Outcomes After Coronary Artery Bypass Grafting Surgery.

Authors:  Heng Zhang; Xin Yuan; Haibo Zhang; Sipeng Chen; Yan Zhao; Kun Hua; Chenfei Rao; Wei Wang; Hansong Sun; Shengshou Hu; Zhe Zheng
Journal:  Circulation       Date:  2015-04-23       Impact factor: 29.690

10.  Coronary artery bypass grafting-related bleeding complications in patients treated with ticagrelor or clopidogrel: a nationwide study.

Authors:  Emma C Hansson; Lena Jidéus; Bengt Åberg; Henrik Bjursten; Mats Dreifaldt; Anders Holmgren; Torbjörn Ivert; Shahab Nozohoor; Mikael Barbu; Rolf Svedjeholm; Anders Jeppsson
Journal:  Eur Heart J       Date:  2015-09-01       Impact factor: 29.983

View more
  1 in total

1.  Gender Particularities and Prevalence of Atypical Clinical Presentation in Non-ST Elevation Acute Coronary Syndrome.

Authors:  Mihai Octavian Negrea; Dumitru Zdrenghea; Minodora Teodoru; Bogdan Neamțu; Călin Remus Cipăian; Dana Pop
Journal:  J Cardiovasc Dev Dis       Date:  2022-03-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.